Both in Biotechnology
Century Therapeutics vs SAB Biotherapeutics
Over the past year IPSC returned +230.3% and SABS returned +65.1%; their daily moves had a correlation of 0.20.
IPSC +230.3% SABS +65.1%Growth of $1, one year, split-adjusted
| Metric | IPSC | SABS |
|---|---|---|
| Price | $1.65 | $3.22 |
| Market cap | $298.8M | $293.0M |
| Today | −1.20% | +0.16% |
| 1 month | −18.5% | −15.0% |
| 6 months | −18.7% | −14.8% |
| Year to date | +65.9% | −13.9% |
| 1 year | +224.1% | +60.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $119.7M | $99.4M |
| Dividend yield | — | — |
| Volatility (60d) | 55.5% | 37.6% |
| Short % of float | 23.5% | 5.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).